Business Economy


Wheels India signs technical agreement with Japan’s Topy industries

Chennai, Dec 15 (UNI) Wheels India has signed a Technical Assistance Agreement with Tokyo,
Japan headquartered Topy Industries for the design, development and manufacture of aluminium alloy
wheels.
As part of this agreement, Topy will provide technical knowhow and engineering support to
enhance Wheels India's design and manufacturing capabilities for the cast aluminium wheel business.
new orders in the domestic market
Wheels India had forayed into the alloy wheel business in FY21 with a state -of- the-art facility at
Thervoy Kandigai on the outskirts of Chennai.
Having started off initially by exporting alloy wheels to
the US and European after-market, the company is now targeting the domestic market and has
commenced supplies to Indian OEMs such as Tata Motors and Stellantis.
The company has also bagged new orders for its aluminium wheels business from Hyundai and
Volkswagen and expects to commence supplies next year.
Commenting on the Japanese agreement, Srivats Ram, MD, Wheels India said, “Topy Industries is
an over 100year old globally renowned wheel manufacturer. They are a leading manufacturer of
aluminium wheels with evolved cutting-edge technologies. This agreement is expected to bring
in considerable technical expertise in the aluminium wheel segment for Wheels India. We are
confident that this agreement will also help us win new businesses and bolster our competitive
advantage in the cast aluminium segment.”
On new opportunities in the Aluminium Wheels segment, Srivats said, “Through this agreement, we
are hoping to make fresh inroads into the Japanese OEMs in India in the alloy wheel segment.”
Wheels India is currently in the process of expanding the annual capacity at its alloy wheels plant in
Thervoi Kandigai to 7 lakh wheels per annum from the existing 5 lakh wheels per annum. This
capacity expansion is expected to be completed by the end of the next quarter.
Buoyed by the prospects in the aluminium wheels segment, the company is planning to further expand
its capacity to 10 lakh wheels per annum next year and this expansion is expected to be completed by
the end of FY27.
Wheels India already has a JV with Topy for its steel wheels business through WIL Car Wheels
Limited having a 74% equity holding. This JV is focused on steel wheels for the Japanese OEMs in
India.
UNI GV 1340
More News

Godrej incorporates subsidiary to enhance financial services presence

14 Jan 2026 | 8:03 PM

Mumbai, Jan 14 (UNI) Godrej Industries Ltd (GIL) has officially announced that it has incorporated a new subsidiary, called Godrej Investment Ltd, as its financial services arm, which will serve as an umbrella holding company for all group financial operations, including its lending businesses.

see more..

Large-Ticket Deals Power Industrial & Warehousing Leasing to 36 9 Mn Sq Ft in 2025: Colliers

14 Jan 2026 | 7:59 PM

Hyderabad, Jan 14( UNI) India’s industrial and warehousing real estate market recorded its strongest performance in recent years, with 36.9 million sq ft of leasing in 2025, registering a 16% year-on-year growth, according to a report released by Colliers India.

see more..

14 Jan 2026 | 7:35 PM

Hyderabad, Jan 14 UNI) : Capital inflows into India’s real estate sector rose sharply in calendar year 2025, reaching an all-time high of USD 14.3 billion, marking a 25 per cent year-on-year growth, according to a latest report ‘ India market Monitor Q4 2025- Investments’ released by CBRE South Asias Pvt Ltd.

see more..

Cyient founder Mohan Reddy receives living leged award by Geospatial World

14 Jan 2026 | 7:18 PM

Hyderabad, Jan 14 (UNI) Cyient, a global Intelligent Engineering solutions company, on Wednesday announced that its Founder Chairman, Dr. B.V.R. Mohan Reddy, has been conferred the ‘Living Legend Award’ by Geospatial World, one of the world’s leading geospatial knowledge organisations.

see more..

Dr Reddy’s launches first to market OTC antihistamine eye drop in US

14 Jan 2026 | 6:54 PM

Hyderabad, Jan 14 (UNI) : Dr. Reddy’s Laboratories on Wednesday announced the first-to-market U.S. launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday® Once-Daily Relief, following approval by the U.S. Food and Drug Administration.

see more..